Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

FDA Grants Accelerated Approval to Lifileucel for Unresectable or Metastatic Melanoma

Ogkologos - 28 Φεβρουαρίου, 2024

At 3-Year Follow-Up Nivolumab Plus Chemotherapy Continued to Demonstrate OS Improvement...

Ogkologos - 27 Φεβρουαρίου, 2024

EMA Recommends Granting a Marketing Authorisation for Retifanlimab

Ogkologos - 26 Φεβρουαρίου, 2024

FDA Approves Osimertinib with Platinum-Based Chemotherapy for EGFR-mutated Locally Advanced or...

Ogkologos - 23 Φεβρουαρίου, 2024

Pump Up the Volume: “Priming Agents” May Improve Cancer Liquid Biopsies

Ogkologos - 22 Φεβρουαρίου, 2024

Activity and Safety of Regorafenib Plus Nivolumab in First-Line Treatment for...

Ogkologos - 22 Φεβρουαρίου, 2024

Longitudinal Profiling of the Gut Microbiome in Patients Undergoing Immune Checkpoint...

Ogkologos - 21 Φεβρουαρίου, 2024

FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer

Ogkologos - 20 Φεβρουαρίου, 2024

ESMO Targeted Anticancer Therapies Congress 2024, 26-28 February, Paris, France

Ogkologos - 20 Φεβρουαρίου, 2024

Efficacy, Safety, and Translational Data from Durvalumab Plus Ceralasertib in Advanced/Metastatic...

Ogkologos - 19 Φεβρουαρίου, 2024

1...909192...440 Σελίδα 91 από 440

MOST POPULAR

Adjuvant fractionated radiotherapy significantly improves DFS in patients with atypical meningioma...

8 Οκτωβρίου, 2026

24-Year-Old Diagnosed With Breast Cancer After Doctors Said Her Chest Was...

27 Ιανουαρίου, 2020

74 & 75-Year-Old Sweethearts Get Married In ICU In Wake Of...

10 Φεβρουαρίου, 2022

Immunotherapy, Liquid Biopsy, and Treatment Combinations: Research from the 2024 ASCO...

18 Ιανουαρίου, 2024

Φόρτωση περισσοτέρων

FDA Grants Accelerated Approval to Lifileucel for Unresectable or Metastatic Melanoma

At 3-Year Follow-Up Nivolumab Plus Chemotherapy Continued to Demonstrate OS Improvement...

EMA Recommends Granting a Marketing Authorisation for Retifanlimab

FDA Approves Osimertinib with Platinum-Based Chemotherapy for EGFR-mutated Locally Advanced or...

Pump Up the Volume: “Priming Agents” May Improve Cancer Liquid Biopsies

Activity and Safety of Regorafenib Plus Nivolumab in First-Line Treatment for...

Longitudinal Profiling of the Gut Microbiome in Patients Undergoing Immune Checkpoint...

FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer

ESMO Targeted Anticancer Therapies Congress 2024, 26-28 February, Paris, France

Efficacy, Safety, and Translational Data from Durvalumab Plus Ceralasertib in Advanced/Metastatic...

MOST POPULAR

Adjuvant fractionated radiotherapy significantly improves DFS in patients with atypical meningioma...

24-Year-Old Diagnosed With Breast Cancer After Doctors Said Her Chest Was...

74 & 75-Year-Old Sweethearts Get Married In ICU In Wake Of...

Immunotherapy, Liquid Biopsy, and Treatment Combinations: Research from the 2024 ASCO...

HOT NEWS

Daratumumab Plus Bortezomib and Dexamethasone Regimen Significantly Prolongs OS in Patients...

How Joining a Clinical Trial Helped Me Find Hope While Living...

Manipulating an Immune Cell May Make Radiation Therapy More Effective, Study...

Asciminib Shows Superior Efficacy Over Investigator-Selected TKIs and Imatinib in Patients...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ